Detalles de la búsqueda
1.
Nilotinib induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-chronic myeloid leukemia.
Am J Hematol
; 93(7): E162-E164, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29633310
2.
Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment.
PLoS One
; 14(7): e0218444, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31318870
3.
Wide-transcriptome analysis and cellularity of bone marrow CD34+/lin- cells of patients with chronic-phase chronic myeloid leukemia at diagnosis vs. 12 months of first-line nilotinib treatment.
Cancer Biomark
; 21(1): 41-53, 2017 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29036785
4.
Microarray demonstrates different gene expression profiling signatures between Waldenström macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.
Clin Lymphoma Myeloma Leuk
; 13(2): 208-10, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23477935
5.
Gene expression profiling identifies ARSD as a new marker of disease progression and the sphingolipid metabolism as a potential novel metabolism in chronic lymphocytic leukemia.
Cancer Biomark
; 11(1): 15-28, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22820137
6.
ZAP-70, IgVh, and cytogenetics for assessing prognosis in chronic lymphocytic leukemia.
Cancer Biomark
; 6(1): 1-9, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20164537
Resultados
1 -
6
de 6
1
Próxima >
>>